Nanoparticle-based theranostic agents

Advanced Drug Delivery Reviews

Volumn 62, Issue 11, 2010, Pages 1064-1079

  Xie, Jin ^a   Lee, Seulki ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Carbon nanotubes; Drug delivery; Gene delivery; Gold nanoparticles; Iron oxide nanoparticles; Molecular imaging; Nanomedicine; Quantum dots; Silica nanoparticles; Theranostics

Indexed keywords

GENE DELIVERY; GOLD NANOPARTICLES; IRON OXIDE NANOPARTICLES; MOLECULAR IMAGING; NANOMEDICINES; QUANTUM DOT; SILICA NANOPARTICLES; THERANOSTICS;

CARBON NANOTUBES; COREMAKING; DRUG DELIVERY; GENE THERAPY; GENE TRANSFER; GOLD; IRON OXIDES; MEDICAL NANOTECHNOLOGY; NANOSYSTEMS; SEMICONDUCTOR QUANTUM DOTS; SILICA; SURFACE CHEMISTRY;

NANOPARTICLES;

ALPHA INTERMEDIN DERIVATIVE; CARBON NANOTUBE; DOXORUBICIN; EPIRUBICIN; GOLD NANOPARTICLE; INSULIN; IRON OXIDE NANOPARTICLE; METHOTREXATE; NANOPARTICLE; PACLITAXEL; PROSTATE SPECIFIC MEMBRANE ANTIGEN; QUANTUM DOT; SILICON DIOXIDE NANOPARTICLE; SINGLE WALLED NANOTUBE; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE; SURVIVIN; TETRAKIS(4 SULFOPHENYL)PORPHINE; TRANSCRIPTION FACTOR RELA; TRASTUZUMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; BIOCOMPATIBILITY; BREAST CANCER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED DRUG RELEASE; DIABETES MELLITUS; ENCAPSULATION; GENE DELIVERY SYSTEM; GENE SILENCING; HUMAN; HYDRODYNAMICS; LEWIS CARCINOMA; MAGNETIC FIELD; MATERIAL COATING; MELANOMA B16; NANOMEDICINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOLUMINESCENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY; THERANOSTICS; TUMOR; TUMOR NECROSIS; TUMOR REGRESSION;

ANIMALS; DIAGNOSTIC IMAGING; DRUG CARRIERS; HUMANS; NANOMEDICINE; NANOPARTICLES; SURFACE PROPERTIES;

EID: 78650169216     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.07.009     Document Type: Review

References (188)

1. Del Vecchio S., Zannetti A., Fonti R., Pace L., Salvatore M. Nuclear imaging in cancer theranostics. Q. J. Nucl. Med. Mol. Imaging 2007, 51:152-163.
2. Nie S., Xing Y., Kim G.J., Simons J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 2007, 9:257-288.
3. Liu Y., Miyoshi H., Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 2007, 120:2527-2537.
4. Cai W., Chen X. Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 2008, 49(Suppl 2):113S-128S.
5. Cai W., Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
6. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006, 58:1471-1504.
7. Park K., Lee S., Kang E., Kim K., Choi K., Kwon I.C. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv. Funct. Mater. 2009, 19:1553-1566.
8. Smith A.M., Duan H., Mohs A.M., Nie S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 2008, 60:1226-1240.
9. Morales M.P., Veintemillas-Verdaguer S., Montero M.I., Serna C.J., Roig A., Casas L., Martinez B., Sandiumenge F. Surface and internal spin canting in gamma-Fe2O3 nanoparticles. Chem. Mater. 1999, 11:3058-3064.
10. Xie J., Huang J., Li X., Sun S., Chen X. Iron oxide nanoparticle platform for biomedical applications. Curr. Med. Chem. 2009, 16:1278-1294.
11. Jun Y.W., Seo J.W., Cheon A. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res. 2008, 41:179-189.
12. Xu C.J., Sun S.H. Monodisperse magnetic nanoparticles for biomedical applications. Polym. Int. 2007, 56:821-826.
13. Chouly C., Pouliquen D., Lucet I., Jeune J.J., Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13:245-255.
14. Corot C., Violas X., Robert P., Gagneur G., Port M. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest. Radiol. 2003, 38:311-319.
15. Duguet E., Vasseur S., Mornet S., Devoisselle J.M. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006, 1:157-168.
16. Edelstein A.S., Cammarata R.C. Institute of Physics (Great Britain), Nanomaterials: Synthesis, Properties, and Applications 1996, Institute of Physics Publishing, Bristol.
17. Fleige G., Seeberger F., Laux D., Kresse M., Taupitz M., Pilgrimm H., Zimmer C. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest. Radiol. 2002, 37:482-488.
18. Grancharov S.G., Zeng H., Sun S.H., Wang S.X., O'Brien S., Murray C.B., Kirtley J.R., Held G.A. Bio-functionalization of monodisperse magnetic nanoparticles and their use as biomolecular labels in a magnetic tunnel junction based sensor. J. Phys. Chem. B 2005, 109:13030-13035.
19. Ito A., Shinkai M., Honda H., Kobayashi T. Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 2005, 100:1-11.
20. Lu A.H., Salabas E.L., Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007, 46:1222-1244.
21. Kang Y.S., Risbud S., Rabolt J.F., Stroeve P. Synthesis and characterization of nanometer-size Fe3O4 and gamma-Fe2O3 particles. Chem. Mater. 1996, 8:2209-2211.
22. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
23. Lanza G.M., Winter P.M., Caruthers S.D., Morawski A.M., Schmieder A.H., Crowder K.C., Wickline S.A. Magnetic resonance molecular imaging with nanoparticles. J. Nucl. Cardiol. 2004, 11:733-743.
24. Mornet S., Vasseur S., Grasset F., Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 2004, 14:2161-2175.
25. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., de la Rosette J., Weissleder R. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J. Med. 2003, 348:2491-2499.
26. Lee H.Y., Li Z., Chen K., Hsu A.R., Xu C., Xie J., Sun S., Chen X. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. J. Nucl. Med. 2008, 49:1371-1379.
27. Pirko I., Johnson A., Ciric B., Gamez J., Macura S.I., Pease L.R., Rodriguez M. In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J. 2003, 17:179-182.
28. Zhao M., Kircher M.F., Josephson L., Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 2002, 13:840-844.
29. Kang H.W., Josephson L., Petrovsky A., Weissleder R., Bogdanov A. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug. Chem. 2002, 13:122-127.
30. Josephson L., Tung C.H., Moore A., Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug. Chem. 1999, 10:186-191.
31. Hogemann D., Ntziachristos V., Josephson L., Weissleder R. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjug. Chem. 2002, 13:116-121.
32. Park J., Lee E., Hwang N.M., Kang M.S., Kim S.C., Hwang Y., Park J.G., Noh H.J., Kini J.Y., Park J.H., Hyeon T. One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew. Chem. Int. Ed. 2005, 44:2872-2877.
33. Kohler N., Fryxell G.E., Zhang M.Q. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J. Am. Chem. Soc. 2004, 126:7206-7211.
34. Kohler N., Sun C., Fichtenholtz A., Gunn J., Fang C., Zhang M.Q. Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small 2006, 2:785-792.
35. Kohler N., Sun C., Wang J., Zhang M.Q. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005, 21:8858-8864.
36. Hwu J.R., Lin Y.S., Josephrajan T., Hsu M.H., Cheng F.Y., Yeh C.S., Su W.C., Shieh D.B. Targeted Paclitaxel by conjugation to iron oxide and gold nanoparticles. J. Am. Chem. Soc. 2009, 131:66-68.
37. Huh Y.M., Jun Y.W., Song H.T., Kim S., Choi J.S., Lee J.H., Yoon S., Kim K.S., Shin J.S., Suh J.S., Cheon J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J. Am. Chem. Soc. 2005, 127:12387-12391.
38. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., Kim S., Cho E.J., Yoon H.G., Suh J.S., Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2007, 13:95-99.
39. Jain T.K., Richey J., Strand M., Leslie-Pelecky D.L., Flask C.A., Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008, 29:4012-4021.
40. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J., Kim K., Jon S. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed Engl. 2008, 47:5362-5365.
41. J. Xie, K. Chen, J. Huang, S. Lee, J. Wang, J. Gao, X. Li, X. Chen, PET/NIRF/MRI triple functional iron oxide nanoparticles, Biomaterials, 31 3016-3022.
42. Piao Y., Kim J., Bin Na H., Kim D., Baek J.S., Ko M.K., Lee J.H., Shokouhimehr M., Hyeon T. Wrap-bake-peel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat. Mater. 2008, 7:242-247.
43. Cheng K., Peng S., Xu C., Sun S. Porous hollow Fe(3)O(4) nanoparticles for targeted delivery and controlled release of cisplatin. J. Am. Chem. Soc. 2009, 131:10637-10644.
44. Medarova Z., Pham W., Farrar C., Petkova V., Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 2007, 13:372-377.
45. Lee J.H., Lee K., Moon S.H., Lee Y., Park T.G., Cheon J. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew. Chem. Int. Ed Engl. 2009, 48:4174-4179.
46. Mornet S., Vasseur S., Grasset F., Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 2004, 14:2161-2175.
47. Ito A., Shinkai M., Honda H., Kobayashi T. Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 2005, 100:1-11.
48. Neuberger T., Schopf B., Hofmann H., Hofmann M., von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005, 293:483-496.
49. Lubbe A.S. Preclinical experiences with magnetic drug targeting: tolerance and efficacy and clinical experiences with magnetic drug targeting: a phase I study with 4?-epidoxorubicin in 14 patients with advanced solid tumors-reply. Cancer Res. 1997, 57:3064-3065.
50. Namiki Y., Namiki T., Yoshida H., Ishii Y., Tsubota A., Koido S., Nariai K., Mitsunaga M., Yanagisawa S., Kashiwagi H., Mabashi Y., Yumoto Y., Hoshina S., Fujise K., Tada N. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat. Nanotechnol. 2009, 4:598-606.
51. Shinkai M., Le B., Honda H., Yoshikawa K., Shimizu K., Saga S., Wakabayashi T., Yoshida J., Kobayashi T. Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn J. Cancer Res. 2001, 92:1138-1145.
52. Primo F.L., Rodrigues M.M., Simioni A.R., Lacava Z.G., Morais P.C., Tedesco A.C. Photosensitizer-loaded magnetic nanoemulsion for use in synergic photodynamic and magnetohyperthermia therapies of neoplastic cells. J. Nanosci. Nanotechnol. 2008, 8:5873-5877.
53. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Parker J.A., Mihaljevic T., Laurence R.G., Dor D.M., Cohn L.H., Bawendi M.G., Frangioni J.V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22:93-97.
54. S. Miao, S.G. Hickey, B. Rellinghaus, C. Waurisch, A. Eychmuller, Synthesis and characterization of cadmium phosphide quantum dots emitting in the visible red to near-infrared, J Am Chem Soc, 132 5613-5615.
55. Zimmer J.P., Kim S.W., Ohnishi S., Tanaka E., Frangioni J.V., Bawendi M.G. Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. J. Am. Chem. Soc. 2006, 128:2526-2527.
56. Xie R., Chen K., Chen X., Peng X. InAs/InP/ZnSe core/shell/shell quantum dots as near-infrared emitters: bright, narrow-band, non-cadmium containing, and biocompatible. Nano Res. 2008, 1:457-464.
57. Kim S.W., Zimmer J.P., Ohnishi S., Tracy J.B., Frangioni J.V., Bawendi M.G. Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. J. Am. Chem. Soc. 2005, 127:10526-10532.
58. Bailey R.E., Smith A.M., Nie S.M. Quantum dots in biology and medicine. Phys. E Low Dimension. Syst. Nanostruct. 2004, 25:1-12.
59. Green M. Semiconductor quantum dots as biological imaging agents. Angew. Chem. Int. Ed Engl. 2004, 43:4129-4131.
60. Medintz I.L., Uyeda H.T., Goldman E.R., Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 2005, 4:435-446.
61. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
62. Kim S., Bawendi M.G. Oligomeric ligands for luminescent and stable nanocrystal quantum dots. J. Am. Chem. Soc. 2003, 125:14652-14653.
63. Pinaud F., King D., Moore H.P., Weiss S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J. Am. Chem. Soc. 2004, 126:6115-6123.
64. Smith A.M., Nie S. Minimizing the hydrodynamic size of quantum dots with multifunctional multidentate polymer ligands. J. Am. Chem. Soc. 2008, 130:11278-11279.
65. Clapp A.R., Medintz I.L., Mauro J.M., Fisher B.R., Bawendi M.G., Mattoussi H. Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. J. Am. Chem. Soc. 2004, 126:301-310.
66. Medintz I.L., Konnert J.H., Clapp A.R., Stanish I., Twigg M.E., Mattoussi H., Mauro J.M., Deschamps J.R. A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. Proc. Natl Acad. Sci. USA 2004, 101:9612-9617.
67. Carion O., Mahler B., Pons T., Dubertret B. Synthesis, encapsulation, purification and coupling of single quantum dots in phospholipid micelles for their use in cellular and in vivo imaging. Nat. Protoc. 2007, 2:2383-2390.
68. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002, 298:1759-1762.
69. Osaki F., Kanamori T., Sando S., Sera T., Aoyama Y. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 2004, 126:6520-6521.
70. Ballou B., Lagerholm B.C., Ernst L.A., Bruchez M.P., Waggoner A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 2004, 15:79-86.
71. Mattheakis L.C., Dias J.M., Choi Y.J., Gong J., Bruchez M.P., Liu J.Q., Wang E. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 2004, 327:200-208.
72. Gao X., Cui Y., Levenson R.M., Chung L.W., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
73. M. Nurunnabi, K.J. Cho, J.S. Choi, K.M. Huh, Y.K. Lee, Targeted near-IR QDs-loaded micelles for cancer therapy and imaging, Biomaterials.
74. Park J.H., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem. Int. Ed Engl. 2008, 47:7284-7288.
75. Bagalkot V., Zhang L., Levy-Nissenbaum E., Jon S., Kantoff P.W., Langer R., Farokhzad O.C. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett. 2007, 7:3065-3070.
76. Yuan J., Guo W., Yang X., Wang E. Anticancer drug-DNA interactions measured using a photoinduced electron-transfer mechanism based on luminescent quantum dots. Anal. Chem. 2009, 81:362-368.
77. Chen A.A., Derfus A.M., Khetani S.R., Bhatia S.N. Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res. 2005, 33:e190.
78. Qi L., Gao X. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. ACS Nano 2008, 2:1403-1410.
79. Yezhelyev M.V., Qi L., O'Regan R.M., Nie S., Gao X. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J. Am. Chem. Soc. 2008, 130:9006-9012.
80. Derfus A.M., Chen A.A., Min D.H., Ruoslahti E., Bhatia S.N. Targeted quantum dot conjugates for siRNA delivery. Bioconjug. Chem. 2007, 18:1391-1396.
81. Bonoiu A., Mahajan S.D., Ye L., Kumar R., Ding H., Yong K.T., Roy I., Aalinkeel R., Nair B., Reynolds J.L., Sykes D.E., Imperiale M.A., Bergey E.J., Schwartz S.A., Prasad P.N. MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res. 2009, 1282:142-155.
82. Samia A.C., Chen X., Burda C. Semiconductor quantum dots for photodynamic therapy. J. Am. Chem. Soc. 2003, 125:15736-15737.
83. Willard D.M., Van Orden A. Quantum dots: resonant energy-transfer sensor. Nat. Mater. 2003, 2:575-576.
84. Bakalova R., Ohba H., Zhelev Z., Ishikawa M., Baba Y. Quantum dots as photosensitizers?. Nat. Biotechnol. 2004, 22:1360-1361.
85. Tsay J.M., Trzoss M., Shi L., Kong X., Selke M., Jung M.E., Weiss S. Singlet oxygen production by peptide-coated quantum dot-photosensitizer conjugates. J. Am. Chem. Soc. 2007, 129:6865-6871.
86. Samia A.C., Dayal S., Burda C. Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy. Photochem. Photobiol. 2006, 82:617-625.
87. Hsieh J.M., Ho M.L., Wu P.W., Chou P.T., Tsai T.T., Chi Y. Iridium-complex modified CdSe/ZnS quantum dots; a conceptual design for bi-functionality toward imaging and photosensitization. Chem. Commun. (Camb) 2006, 615-617.
88. Shi L., Hernandez B., Selke M. Singlet oxygen generation from water-soluble quantum dot-organic dye nanocomposites. J. Am. Chem. Soc. 2006, 128:6278-6279.
89. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
90. Biju V., Itoh T., Anas A., Sujith A., Ishikawa M. Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications. Anal. Bioanal. Chem. 2008, 391:2469-2495.
91. Niemeyer C.M. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew. Chem. Int. Ed. 2001, 40:4128-4158.
92. Hu M., Chen J.Y., Li Z.Y., Au L., Hartland G.V., Li X.D., Marquez M., Xia Y.N. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 2006, 35:1084-1094.
93. Murphy C.J., San T.K., Gole A.M., Orendorff C.J., Gao J.X., Gou L., Hunyadi S.E., Li T. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 2005, 109:13857-13870.
94. Murphy C.J., Sau T.K., Gole A., Orendorff C.J. Surfactant-directed synthesis and optical properties of one-dimensional plasmonic metallic nanostructures. MRS Bull. 2005, 30:349-355.
95. Chen J., Saeki F., Wiley B.J., Cang H., Cobb M.J., Li Z.Y., Au L., Zhang H., Kimmey M.B., Li X.D., Xia Y. Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents. Nano Lett. 2005, 5:473-477.
96. Wang C., Hu Y., Lieber C.M., Sun S. Ultrathin Au nanowires and their transport properties. J. Am. Chem. Soc. 2008, 130:8902-8903.
97. Link S., El-Sayed M.A. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B 1999, 103:4212-4217.
98. Murphy C.J., Sau T.K., Gole A.M., Orendorff C.J., Gao J., Gou L., Hunyadi S.E., Li T. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 2005, 109:13857-13870.
99. Dixit V., Van den Bossche J., Sherman D.M., Thompson D.H., Andres R.P. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug. Chem. 2006, 17:603-609.
100. Oyelere A.K., Chen P.C., Huang X., El-Sayed I.H., El-Sayed M.A. Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug. Chem. 2007, 18:1490-1497.
101. Reynolds A.J., Haines A.H., Russell D.A. Gold glyconanoparticles for mimics and measurement of metal ion-mediated carbohydrate-carbohydrate interactions. Langmuir 2006, 22:1156-1163.
102. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312:1027-1030.
103. Chang J.Y., Wu H.M., Chen H., Ling Y.C., Tan W.H. Oriented assembly of Au nanorods using biorecognition system. Chem. Commun. 2005, 1092-1094.
104. Huang X.H., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano Lett. 2007, 7:1591-1597.
105. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. J. Am. Chem. Soc. 2007, 129:11653-11661.
106. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., Chen D.H., Wang C.R., Shiau A.L., Wu C.L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm. 2007, 4:713-722.
107. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11:169-183.
108. Goel R., Shah N., Visaria R., Paciotti G.F., Bischof J.C. Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine (Lond) 2009, 4:401-410.
109. A.C. Powell, G.F. Paciotti, S.K. Libutti, Colloidal gold: a novel nanoparticle for targeted cancer therapeutics, Methods Mol Biol, 624 375-384.
110. Bhumkar D.R., Joshi H.M., Sastry M., Pokharkar V.B. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res. 2007, 24:1415-1426.
111. Cheng Y., C.S.A, Meyers J.D., Panagopoulos I., Fei B., Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc. 2008, 130:10643-10647.
112. Hone D.C., Walker P.I., Evans-Gowing R., FitzGerald S., Beeby A., Chambrier I., Cook M.J., Russell D.A. Generation of cytotoxic singlet oxygen via phthalocyanine-stabilized gold nanoparticles: a potential delivery vehicle for photodynamic therapy. Langmuir 2002, 18:2985-2987.
113. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 2009, 30:6065-6075.
114. McIntosh C.M., Esposito E.A., Boal A.K., Simard J.M., Martin C.T., Rotello V.M. Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters. J. Am. Chem. Soc. 2001, 123:7626-7629.
115. Han G., Martin C.T., Rotello V.M. Stability of gold nanoparticle-bound DNA toward biological, physical, and chemical agents. Chem. Biol. Drug Des. 2006, 67:78-82.
116. Han G., Chari N.S., Verma A., Hong R., Martin C.T., Rotello V.M. Controlled recovery of the transcription of nanoparticle-bound DNA by intracellular concentrations of glutathione. Bioconjug. Chem. 2005, 16:1356-1359.
117. Thomas M., Klibanov A.M. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc. Natl Acad. Sci. USA 2003, 100:9138-9143.
118. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. Nano Lett. 2007, 7:1591-1597.
119. Skrabalak S.E., Chen J., Sun Y., Lu X., Au L., Cobley C.M., Xia Y. Gold nanocages: synthesis, properties, and applications. Acc. Chem. Res. 2008, 41:1587-1595.
120. Ji X., Shao R., Elliott A.M., Stafford R.J., Esparza-Coss E., Liang G., Luo Z.P., Park K., Markert J.T., Li C. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J. Phys. Chem. C Nanomater. Interfaces 2007, 111:6245.
121. J. Chen, C. Glaus, R. Laforest, Q. Zhang, M. Yang, M. Gidding, M.J. Welch, Y. Xia, Gold nanocages as photothermal transducers for cancer treatment, Small, 6 811-817.
122. Lu W., Xiong C., Zhang G., Huang Q., Zhang R., Zhang J.Z., Li C. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin. Cancer Res. 2009, 15:876-886.
123. W. Lu, G. Zhang, R. Zhang, L.G. Flores, 2nd, Q. Huang, J.G. Gelovani, C. Li, Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection, Cancer Res, 70 3177-3188.
124. Welsher K., Liu Z., D.D, Dai H. Selective probing and imaging of cells with single walled carbon nanotubes as near-infrared fluorescent molecules. Nano Lett. 2008, 8:586-590.
125. Liu Z., Li X., Tabakman S.M., Jiang K., Fan S., Dai H. Multiplexed multi-color Raman imaging of live cells with isotopically modified single walled carbon nanotubes. J. Am. Chem. Soc. 2008, 130:13540-13541.
126. Kam N.W.S., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 2005, 102:11600-11605.
127. Liu J., Rinzler A.G., Dai H., Hafner J.H., Bradley R.K., Boul P.J., Lu A., Iverson T., Shelimov K., Huffman C.B., Rodriguez-Macias F., Shon Y.S., Lee T.R., Colbert D.T., Smalley R.E. Fullerene pipes. Science 1998, 280:1253-1256.
128. Shi Kam N.W., Jessop T.C., Wender P.A., Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into Mammalian cells. J. Am. Chem. Soc. 2004, 126:6850-6851.
129. Jiang K.Y., Schadler L.S., Siegel R.W., Zhang X.J., Zhang H.F., Terrones M. Protein immobilization on carbon nanotubes via a two-step process of diimide-activated amidation. J. Mater. Chem. 2004, 14:37-39.
130. Baker S.E., Cai W., Lasseter T.L., Weidkamp K.P., Hamers R.J. Covalently bonded adducts of deoxyribonucleic acid (DNA) oligonucleotides with single-wall carbon nanotubes: synthesis and hybridization. Nano Lett. 2002, 2:1413-1417.
131. Huang W.J., Taylor S., Fu K.F., Lin Y., Zhang D.H., Hanks T.W., Rao A.M., Sun Y.P. Attaching proteins to carbon nanotubes via diimide-activated amidation. Nano Lett. 2002, 2:311-314.
132. Pompeo F., Resasco D.E. Water solubilization of single-walled carbon nanotubes by functionalization with glucosarnine. Nano Lett. 2002, 2:369-373.
133. Peng H., Alemany L.B., Margrave J.L., Khabashesku V.N. Sidewall carboxylic acid functionalization of single-walled carbon nanotubes. J. Am. Chem. Soc. 2003, 125:15174-15182.
134. Nguyen C.V., Delzeit L., Cassell A.M., Li J., Han J., Meyyappan M. Preparation of nucleic acid functionalized carbon nanotube arrays. Nano Lett. 2002, 2:1079-1081.
135. Katz E., Willner I. Biomolecule-functionalized carbon nanotubes: applications in nanobioelectronics. Chemphyschem 2004, 5:1084-1104.
136. Bianco A., Kostarelos K., Partidos C.D., Prato M. Biomedical applications of functionalised carbon nanotubes. Chem. Commun. (Camb) 2005, 571-577.
137. Islam M.F., Rojas E., Bergey D.M., Johnson A.T., Yodh A.G. High weight fraction surfactant solubilization of single-wall carbon nanotubes in water. Nano Lett. 2003, 3:269-273.
138. Nakashima N., Tomonari Y., Murakami H. Water-soluble single-walled carbon nanotubes via noncovalent sidewall-functionalization with a pyrene-carrying ammonium ion. Chem. Lett. 2002, 638-639.
139. Moore V.C., Strano M.S., Haroz E.H., Hauge R.H., Smalley R.E., Schmidt J., Talmon Y. Individually suspended single-walled carbon nanotubes in various surfactants. Nano Lett. 2003, 3:1379-1382.
140. Chen R.J., Zhang Y.G., Wang D.W., Dai H.J. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J. Am. Chem. Soc. 2001, 123:3838-3839.
141. Kang Y., Taton T.A. Micelle-encapsulated carbon nanotubes: a route to nanotube composites. J. Am. Chem. Soc. 2003, 125:5650-5651.
142. Artyukhin A.B., Bakajin O., Stroeve P., Noy A. Layer-by-layer electrostatic self-assembly of polyelectrolyte nanoshells on individual carbon nanotube templates. Langmuir 2004, 20:1442-1448.
143. Zheng M., Jagota A., Semke E.D., Diner B.A., Mclean R.S., Lustig S.R., Richardson R.E., Tassi N.G. DNA-assisted dispersion and separation of carbon nanotubes. Nat. Mater. 2003, 2:338-342.
144. Zheng M., Jagota A., Strano M.S., Santos A.P., Barone P., Chou S.G., Diner B.A., Dresselhaus M.S., McLean R.S., Onoa G.B., Samsonidze G.G., Semke E.D., Usrey M., Walls D.J. Structure-based carbon nanotube sorting by sequence-dependent DNA assembly. Science 2003, 302:1545-1548.
145. Johnson R.R., Johnson A.T.C., Klein M.L. Probing the structure of DNA-carbon nanotube hybrids with molecular dynamics. Nano Lett. 2008, 8:69-75.
146. Schipper M.L., Nakayama-Ratchford N., Davis C.R., Kam N.W.S., Chu P., Liu Z., Sun X.M., Dai H.J., Gambhir S.S. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat. Nanotechnol. 2008, 3:216-221.
147. Kam N.W., Liu Z., Dai H. Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. Angew. Chem. Int. Ed Engl. 2006, 45:577-581.
148. Jin H., Heller D.A., Strano M.S. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett. 2008, 8:1577-1585.
149. Kostarelos K., Lacerda L., Pastorin G., Wu W., Wieckowski S., Luangsivilay J., Godefroy S., Pantarotto D., Briand J.P., Muller S., Prato M., Bianco A. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2007, 2:108-113.
150. Pantarotto D., Singh R., McCarthy D., Erhardt M., Briand J.P., Prato M., Kostarelos K., Bianco A. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew. Chem. Int. Ed Engl. 2004, 43:5242-5246.
151. Singh R., Pantarotto D., McCarthy D., Chaloin O., Hoebeke J., Partidos C.D., Briand J.P., Prato M., Bianco A., Kostarelos K. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J. Am. Chem. Soc. 2005, 127:4388-4396.
152. Pastorin G., Wu W., Wieckowski S., Briand J.P., Kostarelos K., Prato M., Bianco A. Double functionalization of carbon nanotubes for multimodal drug delivery. Chem. Commun. (Camb) 2006, 1182-1184.
153. Kam N.W., Liu Z., Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J. Am. Chem. Soc. 2005, 127:12492-12493.
154. Liu Z., Winters M., Holodniy M., Dai H. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew. Chem. Int. Ed Engl. 2007, 46:2023-2027.
155. Dhar S., Liu Z., Thomale J., Dai H., Lippard S.J. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. J. Am. Chem. Soc. 2008, 130:11467-11476.
156. Liu Z., Chen K., Davis C., Sherlock S., Cao Q., Chen X., Dai H. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008, 68:6652-6660.
157. Liu Z., Tabakman S., Welsher K., Dai H. Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res. 2009, 2:85-120.
158. Liu Z., Fan A.C., Rakhra K., Sherlock S., Goodwin A., Chen X., Yang Q., Felsher D.W., Dai H. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew. Chem. Int. Ed Engl. 2009, 48:7668-7672.
159. Kam N.W., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc. Natl Acad. Sci. USA 2005, 102:11600-11605.
160. Moon H.K., Lee S.H., Choi H.C. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009, 3:3707-3713.
161. Ghosh S., Dutta S., Gomes E., Carroll D., D'Agostino R., Olson J., Guthold M., Gmeiner W.H. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009, 3:2667-2673.
162. Jana N.R., Earhart C., Ying J.Y. Synthesis of water-soluble and functionalized nanoparticles by silica coating. Chem. Mater. 2007, 19:5074-5082.
163. Ow H., Larson D.R., Srivastava M., Baird B.A., Webb W.W., Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 2005, 5:113-117.
164. Tapec R., Zhao X.J., Tan W. Development of organic dye-doped silica nanoparticles for bioanalysis and biosensors. J. Nanosci. Nanotechnol. 2002, 2:405-409.
165. Hsiao J.K., Tsai C.P., Chung T.H., Hung Y., Yao M., Liu H.M., Mou C.Y., Yang C.S., Chen Y.C., Huang D.M. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 2008, 4:1445-1452.
166. Wolcott A., Gerion D., Visconte M., Sun J., Schwartzberg A., Chen S.W., Zhang J.Z. Silica-coated CdTe quantum dots functionalized with thiols for bioconjugation to IgG proteins. J. Phys. Chem. B 2006, 110:5779-5789.
167. Gerion D., Pinaud F., Williams S.C., Parak W.J., Zanchet D., Weiss S., Alivisatos A.P. Synthesis and properties of biocompatible water-soluble silica-coated CdSe/ZnS semiconductor quantum dots. J. Phys. Chem. B 2001, 105:8861-8871.
168. Kang K., Choi J., Nam J.H., Lee S.C., Kim K.J., Lee S.W., Chang J.H. Preparation and characterization of chemically functionalized silica-coated magnetic nanoparticles as a DNA separator. J. Phys. Chem. B 2009, 113:536-543.
169. Wang C.G., Chen Y., Wang T.T., Ma Z.F., Su Z.M. Monodispersed gold nanorod-embedded silica particles as novel Raman labels for biosensing. Adv. Funct. Mater. 2008, 18:355-361.
170. Lu C.W., Hung Y., Hsiao J.K., Yao M., Chung T.H., Lin Y.S., Wu S.H., Hsu S.C., Liu H.M., Mou C.Y., Yang C.S., Huang D.M., Chen Y.C. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007, 7:149-154.
171. Kim J., Lee J.E., Lee J., Yu J.H., Kim B.C., An K., Hwang Y., Shin C.H., Park J.G., Hyeon T. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc. 2006, 128:688-689.
172. Rieter W.J., Kim J.S., Taylor K.M., An H., Lin W., Tarrant T. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem. Int. Ed Engl. 2007, 46:3680-3682.
173. Salgueirino-Maceira V., Correa-Duarte M.A., Spasova M., Liz-Marzan L.M., Farle M. Composite silica spheres with magnetic and luminescent functionalities. Adv. Funct. Mater. 2006, 16:509-514.
174. Sathe T.R., Agrawal A., Nie S. Mesoporous silica beads embedded with semiconductor quantum dots and iron oxide nanocrystals: dual-function microcarriers for optical encoding and magnetic separation. Anal. Chem. 2006, 78:5627-5632.
175. Selvan S.T., Patra P.K., Ang C.Y., Ying J.Y. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew. Chem. Int. Ed Engl. 2007, 46:2448-2452.
176. Yi D.K., Selvan S.T., Lee S.S., Papaefthymiou G.C., Kundaliya D., Ying J.Y. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J. Am. Chem. Soc. 2005, 127:4990-4991.
177. Koole R., van Schooneveld M.M., Hilhorst J., Castermans K., Cormode D.P., Strijkers G.J., de Mello Donega C., Vanmaekelbergh D., Griffioen A.W., Nicolay K., Fayad Z.A., Meijerink A., Mulder W.J. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug. Chem. 2008, 19:2471-2479.
178. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., Dougherty T.J., Prasad P.N. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 2003, 125:7860-7865.
179. Kim S., Ohulchanskyy T.Y., Pudavar H.E., Pandey R.K., Prasad P.N. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J. Am. Chem. Soc. 2007, 129:2669-2675.
180. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60:1278-1288.
181. Vallet-Regi M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed Engl. 2007, 46:7548-7558.
182. Manzano M., Colilla M., Vallet-Regi M. Drug delivery from ordered mesoporous matrices. Expert Opin. Drug Deliv. 2009, 6:1383-1400.
183. Vivero-Escoto J.L., Slowing I.I., Wu C.W., Lin V.S. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J. Am. Chem. Soc. 2009, 131:3462-3463.
184. Lai C.Y., Trewyn B.G., Jeftinija D.M., Jeftinija K., Xu S., Jeftinija S., Lin V.S. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 2003, 125:4451-4459.
185. Giri S., Trewyn B.G., Stellmaker M.P., Lin V.S. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed Engl. 2005, 44:5038-5044.
186. Mal N.K., Fujiwara M., Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 2003, 421:350-353.
187. Casasus R., Marcos M.D., Martinez-Manez R., Ros-Lis J.V., Soto J., Villaescusa L.A., Amoros P., Beltran D., Guillem C., Latorre J. Toward the development of ionically controlled nanoscopic molecular gates. J. Am. Chem. Soc. 2004, 126:8612-8613.
188. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009, 8:331-336.